They suggest that LOX-1 induced NADPH oxidase activation is modulated by protein kinase C and NADPH oxidase-promoted endothelial dysfunction and MMPs expression is inhibited by AMPK [22]. The gene discussed is FMO5; the disease is endothelial dysfunction.